Laboratorio Farmaceutico Erfo Balance Sheet Health
Financial Health criteria checks 5/6
Laboratorio Farmaceutico Erfo has a total shareholder equity of €8.2M and total debt of €539.5K, which brings its debt-to-equity ratio to 6.6%. Its total assets and total liabilities are €10.7M and €2.5M respectively. Laboratorio Farmaceutico Erfo's EBIT is €968.5K making its interest coverage ratio 37.9. It has cash and short-term investments of €1.7M.
Key information
6.6%
Debt to equity ratio
€539.54k
Debt
Interest coverage ratio | 37.9x |
Cash | €1.73m |
Equity | €8.20m |
Total liabilities | €2.45m |
Total assets | €10.65m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ERFO's short term assets (€4.1M) exceed its short term liabilities (€1.9M).
Long Term Liabilities: ERFO's short term assets (€4.1M) exceed its long term liabilities (€600.6K).
Debt to Equity History and Analysis
Debt Level: ERFO has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ERFO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: ERFO's debt is well covered by operating cash flow (127.8%).
Interest Coverage: ERFO's interest payments on its debt are well covered by EBIT (37.9x coverage).